Navamedic ASA launches Eroxon® Publisert: 12.02.2024 Navamedic ASA acquires innovative antibiotic product for hospital use in the Nordic region Publisert: 23.11.2022 Navamedic ASA launches ForlaxGO® – an innovative on-the-go product for the treatment of constipation Publisert: 20.10.2022 Navamedic ASA – Exclusive agreement with Vectans Pharma for the unique cold sore treatment product Sitavig® Publisert: 04.08.2022 Navamedic ASA acquires Impolin AB and bolsters its product portfolio Publisert: 05.05.2022 Navamedic ASA launches SmectaGO[®] – an innovative on-the-go product for treatment of diarrhea Publisert: 16.02.2022 FørsteForrige12345NesteSiste
Navamedic ASA acquires innovative antibiotic product for hospital use in the Nordic region Publisert: 23.11.2022
Navamedic ASA launches ForlaxGO® – an innovative on-the-go product for the treatment of constipation Publisert: 20.10.2022
Navamedic ASA – Exclusive agreement with Vectans Pharma for the unique cold sore treatment product Sitavig® Publisert: 04.08.2022
Navamedic ASA launches SmectaGO[®] – an innovative on-the-go product for treatment of diarrhea Publisert: 16.02.2022